Mankind Pharma Limited — Important, 15-01-2025: General Updates

The company has received an order from the Additional Commissioner of the Central Goods and Services Tax in Kolkata, imposing a penalty of INR 2.27 crore related to a GST audit covering FY 2017-18 to FY 2021-22. The assessment suggests discrepancies in financial reporting across various statutory returns. However, the company maintains that the order is arbitrary and unjustified, and plans to file an appeal. Importantly, there is no expected material impact on the company's financials or operations as a result of this order. Investors should remain vigilant but note the company’s stance that it will contest this ruling.